MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC. – Trademark Portfolio
Entity Type: 99
MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 4 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MACC FUND. The owner is based in Milwaukee, WI.
10000 Innovation Drive, Suite 135
Milwaukee, WI 53226
Showing of trademarks Trademarks
Trademark Classifications
MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC. have?
MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 3 cancelled.
What trademark classes does MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC. file in?
MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 14 (Jewelry). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC.'s most well-known trademarks?
MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC.'s registered trademark portfolio includes well-known marks such as MACC FUND. These are among 1 currently registered trademark in the portfolio.
What is MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC.'s trademark registration success rate?
MIDWEST ATHLETES AGAINST CHILDHOOD CANCER, INC. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.